|
[1]
|
D’Arcy, M.S. (2019) Cell Death: A Review of the Major Forms of Apoptosis, Necrosis and Autophagy. Cell Biology International, 43, 582-592. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Doran, A.C., Yurdagul Jr, A. and Tabas, I. (2020) Efferocytosis in Health and Disease. Nature Reviews Immunology, 20, 254-267. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Xu, X.B., Lai, Y.Y. and Hua, Z.C. (2019) Apoptosis and Apop-totic Body: Disease Message and Therapeutic Target Potentials. Bioscience Reports, 39, No. 1. [Google Scholar] [CrossRef]
|
|
[4]
|
Duan, H.X.Y., et al. (2021) Suppression of Apoptosis in Vascular Endothelial Cell, the Promising Way for Natural Medicines to Treat Atherosclerosis. Pharmacological Research, 168, Article ID: 105599. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Nagata, S. and Tanaka, M. (2017) Programmed Cell Death and the Immune System. Nature Reviews Immunology, 17, 333-340. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Wong, R.S.Y. (2011) Apoptosis in Cancer: From Pathogenesis to Treatment. Journal of Experimental & Clinical Cancer Re-search, 30, Article No. 87. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Gerl, R. and Vaux, D.L. (2005) Apopto-sis in the Development and Treatment of Cancer. Carcinogenesis, 26, 263-270. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Fisher, S.A., Langille, B.L. and Srivastava, D. (2000) Apoptosis during Cardiovascular Development. Circulation Research, 87, 856-864. [Google Scholar] [CrossRef]
|
|
[9]
|
Frostegård, J. (2013) Immunity, Atherosclerosis and Cardiovascu-lar Disease. BMC Medicine, 11, Article No. 117. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Campia, U., Gerhard-Herman, M., Piazza, G. and Goldhaber, S.Z. (2019) Peripheral Artery Disease: Past, Present, and Future. The American Journal of Medicine, 132, 1133-1141. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Libby, P. (2021) The Changing Landscape of Atherosclerosis. Nature, 592, 524-533. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Li, M., et al. (2022) Programmed Cell Death in Atherosclerosis and Vascular Calcification. Cell Death & Disease, 13, Article No. 467. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Gauthier, J., Vincent, A.T., Charette, S.J. and Derome, N. (2019) A Brief History of Bioinformatics. Briefings in Bioinformatics, 20, 1981-1996. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Davies, M.J. (1997) Apoptosis in Cardiovascular Disease. Heart, 77, 498-501. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Wang, Z.Q., et al. (2019) Nε-Carboxymethyl-Lysine-Induced PI3K/Akt Signaling Inhibition Promotes foam Cell Apoptosis and Atherosclerosis Progression. Biomedicine & Phar-macotherapy, 115, Article ID: 108880. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Fasolo, F., et al. (2021) Long Noncoding RNA MIAT Controls Advanced Atherosclerotic Lesion Formation and Plaque Destabilization. Circulation, 144, 1567-1583. [Google Scholar] [CrossRef]
|
|
[17]
|
Luo, S., et al. (2022) NRP2 Promotes Athero-sclerosis by Upregulating PARP1 Expression and Enhancing Low Shear Stress-Induced Endothelial Cell Apoptosis. The FASEB Journal, 36, e22079. [Google Scholar] [CrossRef]
|
|
[18]
|
Huang, H.M., et al. (2019) Identifica-tion of Biomarkers in Macrophages of Atherosclerosis by Microarray Analysis. Lipids in Health and Disease, 18, Article No. 107. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Dubois-Deruy, E., Peugnet, V., Turkieh, A. and Pinet, F. (2020) Oxidative Stress in Cardiovascular Diseases. Antioxidants (Basel), 9, 864. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Yao, T., Fujimura, T., Murayama, K., Okumura, K. and Seko, Y. (2022) Oxidative Stress-Responsive Apoptosis Inducing Protein (ORAIP) Plays a Critical Role in Doxorubicin-Induced Apop-tosis in Rat Cardiac Myocytes. International Journal of Cardiology, 348, 119-124. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Jandeleit-Dahm, K., Watson, A. and Soro-Paavonen, A. (2008) The AGE/RAGE Axis in Diabetes-Accelerated Atherosclerosis. Clinical and Experimental Pharmacology and Physiol-ogy, 35, 329-334. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Dong, Y., et al. (2023) Targeting Epsins to Inhibit Fibro-blast Growth Factor Signaling While Potentiating Transforming Growth Factor-β Signaling Constrains Endotheli-al-to-Mesenchymal Transition in Atherosclerosis. Circulation, 147, 669-685. [Google Scholar] [CrossRef]
|
|
[23]
|
Zhang, L., et al. (2021) Th17/IL-17 Induces En-dothelial Cell Senescence via Activation of NF-κB/p53/Rb Signaling Pathway. Laboratory Investigation, 101, 1418-1426. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Orecchioni, M., et al. (2022) Olfactory Receptor 2 in Vascular Macrophages Drives Atherosclerosis by NLRP3- Dependent IL-1 Production. Science, 375, 214-221. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Zheng, Y., et al. (2022) Mettl14 Mediates the Inflammatory Response of Macrophages in Atherosclerosis through the NF-κB/IL-6 Signaling Pathway. Cellular and Molecular Life Sciences, 79, Article No. 311. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Tibolla, G., et al. (2010) Increased Atherosclerosis and Vascular Inflammation in APP Transgenic Mice with Apolipoprotein E Deficiency. Atherosclerosis, 210, 78-87. [Google Scholar] [CrossRef] [PubMed]
|